AUPH
Aurinia Pharmaceuticals Inc
3.07%
$8.48 - $8.74
Feb 8th 2023 - Mar 22nd 2023
Mar, 15, 2023
That coupled with his sexual orientation makes him... See more
Mar, 9, 2023
$AUPH Aurinia Pharmaceuticals stock nice breakout,... See more
SRNE
Sorrento Therapeutics Inc
-69.12%
$1.02 - $0.32
Feb 2nd 2023 - Mar 10th 2023
Feb, 5, 2023
$SRNE canni med therapeutics 🙂
Jan, 4, 2023
$SRNE Sorrento Therapeutics Inc (SRNE) is higher b... See more
Mar, 15, 2023
That coupled with his sexual orientation makes him the perfect choice as spokesperson for Aurinia Pharmaceuticals".
Mar, 9, 2023
$AUPH Aurinia Pharmaceuticals stock nice breakout, from Stocks To Watch , see https://stockconsultant.com/?AUPH
Mar, 6, 2023
$AUPH TheFly 13:45 Options Aurinia Pharmaceuticals call volume above normal and directionally bullish Bullish option flow detected in Aurinia Pharmaceuticals with 4,202 calls trading, 2x expected, and implied vol increasing over 1 point to 77.75%.
Jan, 29, 2023
Market for novel LN therapeutics annually ~$1 to $2B for US + EU & Japan = make $AUPH a good offer!
Jan, 8, 2023
Market for novel LN therapeutics annually ~$1B-1.5B peak sales up (IP2037) = make $AUPH a good offer!!!
Jan, 4, 2023
Market for novel LN therapeutics annually ~$1 to $2B for US + EU & Japan = make $AUPH a good offer!
Nov, 20, 2022
Market for novel LN therapeutics annually ~$1 to $2B for US + EU & Japan = make $AUPH a good offer!
Feb, 5, 2023
$SRNE canni med therapeutics 🙂
Jan, 4, 2023
$SRNE Sorrento Therapeutics Inc (SRNE) is higher by Tuesday morning, with the stock rising 26.97% in pre-market trading to 1.13.
Dec, 21, 2022
He wants to thank you for your investment in Sorrento therapeutics. !
Dec, 19, 2022
61% of employees would recommend working at Sorrento Therapeutics to a friend and 69% have a positive outlook for the business.Nov 7, 2022 No kidding.
Dec, 19, 2022
$SRNE Buy, Buy, Pharmaceutical is gonna bounce big in Q1 2023 🏆✅ Hanukkah 🕎
Dec, 19, 2022
$SLNO Soleno Therapeutics up 115%.
Dec, 13, 2022
The company is considered to have the greatest growth outlook as it focuses on developing and commercializing therapeutics in high-value areas.
Dec, 13, 2022
It was a nice percentage gain and Sorrento therapeutics is heading to the OTC pink sheets heading to pennyland